BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27501049)

  • 1. Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.
    Attar-Schneider O; Drucker L; Gottfried M
    Lab Invest; 2016 Sep; 96(9):1004-15. PubMed ID: 27501049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.
    Attar-Schneider O; Pasmanik-Chor M; Tartakover-Matalon S; Drucker L; Lishner M
    Oncotarget; 2015 Feb; 6(6):4315-29. PubMed ID: 25717031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
    Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
    Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting eIF4GI translation initiation factor affords an attractive therapeutic strategy in multiple myeloma.
    Attar-Schneider O; Drucker L; Zismanov V; Tartakover-Matalon S; Lishner M
    Cell Signal; 2014 Sep; 26(9):1878-87. PubMed ID: 24815186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
    Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
    J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
    Attar-Schneider O; Zismanov V; Drucker L; Gottfried M
    Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
    Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
    Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
    Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
    Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mesenchymal stem cells' secretome on lung cancer progression is contingent on their origin: primary or metastatic niche.
    Attar-Schneider O; Drucker L; Gottfried M
    Lab Invest; 2018 Dec; 98(12):1549-1561. PubMed ID: 30089856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer.
    Pang W; Tian X; Bai F; Han R; Wang J; Shen H; Zhang X; Liu Y; Yan X; Jiang F; Xing L
    Mol Cancer; 2014 Oct; 13():240. PubMed ID: 25342548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and function of the second eIF4E-binding region in N-terminal domain of eIF4G: comparison with eIF4E-binding protein.
    Umenaga Y; Paku KS; In Y; Ishida T; Tomoo K
    Biochem Biophys Res Commun; 2011 Oct; 414(3):462-7. PubMed ID: 21964297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.
    Li S; Fu J; Lu C; Mapara MY; Raza S; Hengst U; Lentzsch S
    Mol Cancer Ther; 2016 Apr; 15(4):711-9. PubMed ID: 26939700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic.
    Attar-Schneider O; Dabbah M; Drucker L; Gottfried M
    Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
    Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
    Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
    Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
    J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA cap.
    Yanagiya A; Svitkin YV; Shibata S; Mikami S; Imataka H; Sonenberg N
    Mol Cell Biol; 2009 Mar; 29(6):1661-9. PubMed ID: 19114555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma.
    Cao J; Sun X; Zhang X; Chen D
    Clin Transl Oncol; 2018 Jun; 20(6):761-767. PubMed ID: 29086249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.